SCHEMBL26970080

SCHEMBL26970080

C[C@H](C(=O)O)[C@H]1C[C@@H](c2ccc(C(F)(F)F)cc2)CN(Cc2ccc(C(F)(F)F)cc2)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HIF1A Q16665 3/20 0.45
▸ EPAS1 Q99814 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ FAAH O00519 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ CHRM5 P08912 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ S1PR5 Q9H228 2/20 0.42
▸ S1PR1 P21453 2/20 0.42
▸ GRK5 P34947 1/20 0.42
▸ CDK8 P49336 1/20 0.42
▸ SIGMAR1 Q99720 2/20 0.41
▸ TACR1 P25103 1/20 0.40
▸ TEAD1 P28347 1/20 0.40
▸ MDM2 Q00987 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29617642 1.00 L3MBTL1 (0.46) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL29617606 1.00 L3MBTL1 (0.46) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL27136637 1.00 L3MBTL1 (0.46) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL29617617 0.88 L3MBTL1 (0.47) L3MBTL1HIF1AEPAS1KDM4EFAAH
SCHEMBL29087693 0.87 HIF1A (0.43) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL29087696 0.87 HIF1A (0.43) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL4495877 0.82 PSEN1 (0.43) L3MBTL1KDM4EALDH1A1TEAD1MDM2
SCHEMBL29087753 0.80 HIF1A (0.41) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL29087751 0.80 HIF1A (0.41) L3MBTL1HIF1AEPAS1KDM4EALDH1A1
SCHEMBL4517269 0.78 LMNA (0.42) HIF1AEPAS1KCNH2SIGMAR1MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230416202-A1 Small Molecule Compounds and Compositions TELO THERAPEUTICS, INC. 2023-12-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416202-A1 Small Molecule Compounds and Compositions TERT, TP53, EP300 L3MBTL1 681/4885HIF1A 2084/4885EPAS1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback